RT Journal Article
SR Electronic
T1 Assessment of Vaccine Managers’ Knowledge and Observance of Vaccination Norms and Standards in an Urban Health District of Yaounde (Cameroon) during the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.07.24316922
DO 10.1101/2024.11.07.24316922
A1 Lekeumo Cheuyem, Fabrice Zobel
A1 Amani, Adidja
A1 Ajong, Brian Ngongheh
A1 Noa Otsali, Raissa Katy
A1 Nouko, Ariane
A1 Guissana, Edwige Omona
A1 Ngos, Christelle Sandrine
A1 Mohamadou, Adama
A1 Nloga, Guy Stephane
A1 Edzamba, Michel Franck
A1 Bitye Bi Mvondo, Esther Andriane
A1 Eyenga Ntsek, Larissa Linda
A1 Mouangue, Christian
A1 Nkongo, Florence Kissougle
YR 2024
UL http://medrxiv.org/content/early/2024/11/18/2024.11.07.24316922.abstract
AB Background Routine childhood immunization remains a highly cost-effective public health intervention. Global immunization efforts have increased the coverage of proxy antigens in recent decades. However, annual reports indicated a progressive decline in immunization coverage in Yaounde. This study aimed to identify knowledge gaps and organizational deficiencies in the implementation of routine immunization in health facilities (HFs) in the Efoulan Health District (HD) of Yaounde.Methods A descriptive cross-sectional study was conducted in Efoulan, an urban HD of Yaounde, the capital of Cameroon, in May 2022. A self-administered questionnaire was used to collect knowledge data from consenting HCWs. An observation grid was used to assess the implementation of some relevant national EPI guidelines and recommendations.Results A total of 46 HCWs providing vaccinations in the nine health areas of HDs were enrolled in the study. Almost all participants (93.5%) were unable to name all the diseases that the pentavalent vaccine protects against. More than half of the respondents (59%) were aware of the 15-month booster dose of the measles-rubella (MR) vaccine included in the EPI. Half of the respondents were aware of the type of antigen contained in the BCG vaccine (52%). More than two-thirds of the respondents (72%) had not identified the 6-month MR vaccine as recommended without risk for HIV+ children. Most of the respondents were not aware of the management of opened nonlyophilized vials (50%), calculation of the wastage factor (89%) or vaccine requirements (98%). Almost all the respondents (87%) had poor knowledge of vaccination norms and standards. Most of the visited HFs did not follow the monthly EPI monitoring curve (87%), did not store vaccines according to standards (80%), or had an EPI case reporting form (93%). Most of the consultants in visited HFs were not familiar with the case definitions of common vaccine- preventable diseases.Conclusions The implementation of routine immunization remained poor in most of the HFs in Efoulan HDs because of the lack of knowledge of the EPI norms and standards of the staff. There is a need to strengthen the capacities of HCWs through ongoing training and supervision.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the Faculty of Medicine of Yaounde waived ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript